HEALTHCARE INVESTMENTS

ARKIN PHARMA

PHARMACEUTICALS & BIOTECHNOLOGY
ARKIN PHARMA

Mr. Arkin is one of Israel’s most successful life sciences and pharmaceutical entrepreneurs. He has extensive experience in the development and commercialization of pharmaceutical drug products, having held leadership roles in several medical companies, and has significant ties to leading innovative and generic drug companies. Among other positions, Mr. Arkin headed Agis Industries, growing it into a leading dermatological company in the U.S. until its acquisition by Perrigo in 2005 for $850 million. Mr. Arkin recently completed an acquisition by Merck of cCAM Therapeutics for $605 million. Mr. Arkin has a degree in psychology and philosophy from the Tel Aviv University.

DR. PINI ORBACH – HEAD OF PHARMA

Dr. Pini Orbach joined Arkin Holdings in February 2010 as Head of its Pharma Division and member of the board in several of its pharmaceutical companies, where he shares his vast hands-on drug development experience. He holds a Ph.D., from the Department of Physiology and Functional Genomics, University of Florida, and was a postdoctoral fellow at the Cardiovascular Research Center, Harvard Medical School - Massachusetts General Hospital.